Fundraising FoxEiger BioPharmaceuticals
Santa Clara, US · 4 known investors
Find your way into Eiger BioPharmaceuticals
Sign up to see every warm intro you have to Eiger BioPharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eiger BioPharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JG
Jeffrey GlennNamed on SEC filing
DC
David CoryNamed on SEC filing
Board
Investors · 4
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
Canaan PartnersinferredStamford · $500K – $20Mvia Nina Kjellson · board
How we know: board seat on SEC Form D · Not right? Tell us
Vivo CapitalinferredPalo Alto · $10M – $50Mvia Edgar G. Engleman · board
How we know: board seat on SEC Form D · Not right? Tell us
Vivo Venturesreported
How we know: fiercebiotech.com · Not right? Tell us
Funding
SEC filings, press & company announcements$20.5M disclosed across 2 of 3 rounds · 2009–2015
- Undisclosed amountSeries AFeb 2009
InterWest Partners (lead), Vivo Ventures (lead)
Source ↗
▶$6MraisedNov 2015 · 4 investors · BiotechnologyRule 506(b)
▶$6MraisedNov 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas DietzDirector
- David CoryExecutive Officer, Director
- Nina KjellsonDirector
- Ed EnglemanDirector
- Jeffrey GlennDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedMar 2015 · 8 investors · BiotechnologyRule 506(b)
▶$14.5MraisedMar 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nina KjellsonDirector
- Ed EnglemanDirector
- Jeffrey GlennDirector
- David CoryExecutive Officer, Director
- Offering amount
- $14.6M
- Amount sold
- $14.5M
- First sale
- Apr 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Eiger BioPharmaceuticals's investors?
- Eiger BioPharmaceuticals's investors include Pfizer Venture Investments, Canaan Partners, Vivo Capital, Vivo Ventures.
- How much funding has Eiger BioPharmaceuticals raised?
- Eiger BioPharmaceuticals has disclosed $20.5M raised across 2 of its 3 known rounds.
- Where is Eiger BioPharmaceuticals headquartered?
- Eiger BioPharmaceuticals is headquartered in Santa Clara, US.